Career Enhancement Program
Career Enhancement Program
批准号:
10705250
负责人:
JOHN H. SAMPSON
金额:
$10.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-24 至 2024-08-31
关键词:
AccelerationAdvertisementsAttentionAwardBasic ScienceBrainBrain NeoplasmsCancer CenterCancer Center Planning GrantClinicalClinical SciencesCommunitiesDedicationsDiagnosisDoctor of PhilosophyEducationEffectivenessEligibility DeterminationEvaluationEvolutionFacultyFeedbackFundingGoalsGrantHealth Disparities ResearchHistorically Black Colleges and UniversitiesInfrastructureInstitutionInvestigationJournalsLeadershipMalignant neoplasm of brainMedical StudentsMedicineMentorsMinorityModelingNorth CarolinaNotificationPatient-Focused OutcomesPeer ReviewPlayPositioning AttributePostdoctoral FellowPreventionPrimary Brain NeoplasmsProbabilityProgress ReportsResearchResearch PersonnelResearch Project GrantsResearch SupportRoleRotationSourceStudentsTestingTrainingTraining and EducationTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesUpdateWomanWritingcancer health disparitycandidate identificationcareergraduate studentimprovedimproved outcomeinterestmedical schoolsmeetingsmemberneuro-oncologynext generationnovelnovel strategiespeerpost-doctoral trainingprogramsrecruittranslational potentialtumor diagnosis
中文摘要
摘要-职业提升计划(CEP)
职业提升计划(CEP)通过提供种子,在杜克大学的脑孢子中发挥着不可或缺的作用
支持具有翻译潜力的试验性研究项目,这些项目来自有前途的新的和早期的研究者。
在杜克大学内部和外部广泛协作的项目;测试新概念和
将新方法带入该领域的范例;并进一步扩大脑瘤的范围
将优先提供诊断、预防和管理支持。CEP的具体目标是:1)
确定并支持由NIH指定的新或早期调查人员领导的有价值的翻译项目
有很大可能影响脑肿瘤的诊断、治疗或预防;2)招募和
留住有前途的女性和少数族裔新的和早期的研究人员,职业重点是翻译
神经肿瘤学研究;3)促进获得领导力培训计划和非常成功的
资助编写计划,包括指导新的和早期的研究人员,以使这些教员
成员获得独立教员地位,重点是神经肿瘤学研究;以及4)提供
继续评价受资助项目的进展情况,并促进这些项目演变为完整的孢子项目或
自主出资的项目。通过开发下一代调查人员和新的
调查既可以取代孢子内部的项目,也可以作为独立的、外部的进展
支持的研究项目,CEP发挥关键作用,推动该计划的目标,以克服
恶性脑瘤治疗的局限性。
英文摘要
ABSTRACT – Career Enhancement Program (CEP)
The Career Enhancement Program (CEP) plays an integral role in the Duke Brain SPORE by providing seed
support for pilot research projects with translational potential from promising new and early stage investigators.
Projects that are broadly collaborative both within and external to Duke; that test novel concepts and
paradigms that bring new approaches into the field; and that further expand the scope of the brain tumor
diagnosis, prevention, and management will be prioritized for support. The Specific Aims of the CEP are: 1)
Identify and support meritorious translational projects led by NIH-designated new or early stage investigators
that have a high probability of impacting the diagnosis, treatment or prevention of brain tumors; 2) Recruit and
retain promising women and minority new and early stage investigators with a career focus in translational
neuro-oncology research; 3) Facilitate access to programs for leadership training and a highly successful
program for grant writing that includes mentoring of new and early stage investigators to enable such faculty
members to achieve independent faculty status with emphasis on neuro-oncology research; and 4) Provide
continuing evaluation of progress on funded projects and facilitate their evolution into full SPORE projects or
independently funded projects. By developing the next generation of investigators and new lines of
investigation that can either replace projects within the SPORE or progress as independent, externally
supported research projects, the CEP plays a critical role advancing the Program's goal to overcome
limitations in malignant brain tumor therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10477341
-
项目类别:
-
资助金额:$17.04万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
-
批准号:10006177
-
项目类别:
-
资助金额:$69.14万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
-
批准号:10310436
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
Administrative Core
-
批准号:10246888
-
项目类别:
-
资助金额:$17.53万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
-
批准号:10246884
-
项目类别:
-
资助金额:$63.14万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
Administrative Core
-
批准号:10006180
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2018
-
负责人:JOHN H. SAMPSON
-
依托单位:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
-
批准号:10055778
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2016
-
负责人:JOHN H. SAMPSON
-
依托单位:
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
-
批准号:9216208
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2016
-
负责人:JOHN H. SAMPSON
-
依托单位:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
-
批准号:9750830
-
项目类别:
-
资助金额:$87.11万
-
财政年份:2015
-
负责人:JOHN H. SAMPSON
-
依托单位:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
-
批准号:9095464
-
项目类别:
-
资助金额:$102.44万
-
财政年份:2015
-
负责人:JOHN H. SAMPSON
-
依托单位:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
-
批准号:8803629
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2015
-
负责人:JOHN H. SAMPSON
-
依托单位:
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
-
批准号:9308039
-
项目类别:
-
资助金额:$173.65万
-
财政年份:2015
-
负责人:JOHN H. SAMPSON
-
依托单位:
Administrative Core
-
批准号:8805236
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors
-
批准号:8805238
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
-
批准号:8922079
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
-
批准号:10705242
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
-
批准号:9094714
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Developmental Research Program
-
批准号:10248319
-
项目类别:
-
资助金额:$7.54万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
-
批准号:8805237
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
-
批准号:8673137
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2014
-
负责人:JOHN H. SAMPSON
-
依托单位:
海外基金